Home// - Biovalve’s Mini-Ject technology
Are you sure you want to exit?
Any unsave changes will be lost.
Biovalve’s Mini-Ject technology
Biovalve
Category
Vaccination monitoring
Country
United Kingdom
Description
The Mini-Ject can deliver a wide range of drugs, ranging from small molecules to large proteins, fragile antibodies, and vaccines. Delivery can be targeted to intradermal, subcutaneous or intramuscular depending on the clinical need.